Looking forward to at least 06, geez. What a bloodbath. If they do get approval of their IND though this shoot to .25 without looking back. Should hear something soon now that they hired an outside consulting specializing in electronic submissions.
Perfect storm of convertibles exercising and a very weird belated rejection of a paper IND submission by FDA over Covid. Guess they have a pretty large Covid backlog. Why did FDA sit on this so long? Electronic submission of IND should not take that long, and the folks who exercised convertibles looking to get in ahead of a run can't too happy right now sitting on shares they intended to flip. Best scenario is this thing goes POP when they get the IND on track...or other news in the meantime.
Obviously, this is not Johnson & Johnson or Pfizer. The reason I invested in this company is because it sounds promising and what they are trying to accomplish although on a limited scale. Hoping for the best.GLTA!